Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Farmaceutici Italia SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmaceutici Italia SpAfiledCriticalFarmaceutici Italia SpA
Publication of ES284046A1publicationCriticalpatent/ES284046A1/es
C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
Landscapes
Chemical & Material Sciences
(AREA)
Organic Chemistry
(AREA)
Nitrogen Condensed Heterocyclic Rings
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
ES284046A1962-01-111963-01-10Un procedimiento para la preparación de una nueva clase de derivados de la 6-metil y 1,6-dimetil-ergolina i
ExpiredES284046A1
(es)